Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors (original) (raw)
- Short Report
- Published: 23 November 2001
Oncogene volume 20, pages 7812–7816 (2001)Cite this article
- 1924 Accesses
- 143 Citations
- Metrics details
Abstract
Tumor promoters are non-mutagenic chemicals which increase the probability of cancer by accelerating the clonal expansion of cells transformed during tumor initiation. Phenobarbital (PB) is an antiepileptic drug which promotes hepatocarcinogenesis in rodents when administered subsequent to an initiating carcinogen like diethylnitrosamine (DEN). Here we have investigated the prevalence and patterns of mutations in two genes, Ha-ras and β-catenin, both known mutational targets in mouse hepatocarcinogenesis. Liver tumors were generated by a single administration of DEN to 6 week old mice followed by feeding of PB (0.05%) containing or control diet for 39 weeks. Mutations at Ha-ras codon 61 were screened by allele-specific oligonucleotide hybridization; β-catenin mutations were detected by direct sequencing of PCR products spanning exon 2. In tumors from mice treated with DEN alone, the prevalence of Ha-ras mutations was ∼30% (6/20), while no β-catenin mutations (0/13) were detectable in tumors of this treatment group. By contrast, Ha-ras mutations were undetectable in tumors from mice treated with DEN/PB (0/32), while ∼80% (37/46) of tumors from this group showed β-catenin mutations. These results demonstrate that PB strongly affects the prevalence of mutations in the two cancer-related genes, presumably by positive and negative selection for cells harboring the respective mutation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Bauer-Hofmann R, Klimek F, Buchmann A, Müller O, Bannasch P, Schwarz M . 1992 Mol. Carcinogen. 6: 60–67
- Buchmann A, Bauer-Hofmann R, Mahr J, Drinkwater NR, Luz A, Schwarz M . 1991 Proc. Natl. Acad. Sci. USA 88: 911–915
- de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C . 1998 Proc. Natl. Acad. Sci. USA 95: 8847–8851
- Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC . 1999 Oncogene 18: 4726–4733
- Dragan YP, Pitot HC . 1992 Carcinogenesis 13: 739–750
- Frey S, Buchmann A, Bursch W, Schulte-Hermann R, Schwarz M . 2000 Carcinogenesis 21: 161–166
- Grasl-Kraupp B, Huber W, Gerbracht U, Schulte-Hermann R . 1990 Cancer Res. 50: 3701–3708
- Marshall CJ, Nigg EA . 1998 Curr. Opin. Genet. Dev. 8: 11–13
- Moennikes O, Buchmann A, Romualdi A, Ott T, Werringloer J, Willecke K, Schwarz M . 2000 Cancer Res. 60: 5087–5091
- Morin PJ . 1999 BioEssays 21: 1021–1030
- Ogawa K, Yamada Y, Kishibe K, Ishizaki K, Tokusashi Y . 1999 Cancer Res. 59: 1830–1833
- Schulte-Hermann R, Grasl-Kraupp B, Bursch W . 1995 Liver Regeneration and Carcinogenesis. Jirtle R (ed) Academic Press: San Diego pp. 141–178
- Willert K, Nusse R . 1998 Curr. Opin. Gen. Dev. 8: 95–102
- Yamasaki H, Naus CC . 1996 Carcinogenesis 17: 1199–1213
Acknowledgements
We thank Dr T Devereux for gift of β-catenin-mutated DNAs which were used as positive controls during the initial phases of the project. The excellent technical assistence of Mrs J Mahr and Mrs E Zabinsky is acknowledged. This study was supported in part by the Deutsche Forschungsgemeinschaft (SCHW 329/3-1).
Author information
Authors and Affiliations
- Institut für Toxikologie, Universität Tübingen, Wilhelmstr. 56, 72074 Tübingen, Germany
Huriye Aydinlik, Tri Dung Nguyen, Oliver Moennikes, Albrecht Buchmann & Michael Schwarz
Authors
- Huriye Aydinlik
You can also search for this author inPubMed Google Scholar - Tri Dung Nguyen
You can also search for this author inPubMed Google Scholar - Oliver Moennikes
You can also search for this author inPubMed Google Scholar - Albrecht Buchmann
You can also search for this author inPubMed Google Scholar - Michael Schwarz
You can also search for this author inPubMed Google Scholar
Corresponding author
Correspondence toMichael Schwarz.
Rights and permissions
About this article
Cite this article
Aydinlik, H., Nguyen, T., Moennikes, O. et al. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors.Oncogene 20, 7812–7816 (2001). https://doi.org/10.1038/sj.onc.1204982
- Received: 29 May 2001
- Revised: 11 September 2001
- Accepted: 18 September 2001
- Published: 23 November 2001
- Issue Date: 22 November 2001
- DOI: https://doi.org/10.1038/sj.onc.1204982